Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans

UNC Libraries(2021)10.17615/phnx-3j92Source: DataRank Database

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans is a research paper published in UNC Libraries (2021). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: greenTopics (31)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (31)

Kathryn E. Stephenson ORCID,Jingyou Yu ORCID,Aiquan Chang ORCID,Johan Van Hoof,Sally Shin ORCID

Live enrichment

PubMed:19767382 OpenAlex:https://openalex.org/W4287536494

National Institutes of Health

Grant: 5T32AI007151-42

Infectious Disease Pathogenesis Research Training Program

National Institutes of Health

Grant: 3U01CA260476-02S2

Immunologic Signatures of SARS-CoV-2 Vaccination and Disease

National Institutes of Health

Grant: 1F32AI152296-01A1

Defining viral and immune mechanisms of Dengue virus serotype 2 immune evasion

FWCI

0.00

Citation Percentile

0.2%

greenLicense: CC BY

repositoryhttps://cdr.lib.unc.edu/downloads/gh93h751c

repositoryhttps://doi.org/10.17615/phnx-3j92

https://doi.org/10.1038/s41586-021-03681-2

https://www.nature.com/articles/s41586-021-03681-2.pdf

https://dx.doi.org/10.17615/phnx-3j92

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approaches0303 health sciences03 medical and health sciences

Keywords

ImmunogenicitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)BiologyVirology2019-20 coronavirus outbreakGeneticsComputational biologyMedicineImmune systemOutbreakAdultImmunity, CellularCOVID-19 VaccinesAd26COVS1AdolescentSARS-CoV-2COVID-19Middle AgedAntibodies, ViralAntibodies, NeutralizingArticleImmunity, HumoralYoung AdultSpike Glycoprotein, CoronavirusHumans

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Zero hunger